SB 336: Relating to health benefit plan coverage of treatments for pediatric neuroinflammatory disorder.
- Session
- 90th Texas Legislature, Regular Session
- Status
- Filed
- Filed
- Nov 10, 2026
- Most recent action
- 11/10/2026 S Filed
- Authors
- Menéndez
- Official subjects
- Health--Children's Insurance; Health--Other Diseases & Medical Conditions; Insurance--Health & Accident; INSURANCE, COMMISSIONER OF; INSURANCE, TEXAS DEPARTMENT OF
AI summary (not official): Requires covered health plans to cover qualifying treatment for children with diagnosed neuroinflammatory disorders.
Topics: Healthcare, Business regulation. From AI review or caption rules.
Agencies it could affect (possible, not confirmed): Employees Retirement System of Texas, Texas Department of Insurance, Teacher Retirement System of Texas. From AI review or caption rules.
Laws this bill changes
- amends Insurance Code chapter 1367
- adds Insurance Code § 1367.351
- adds Insurance Code § 1367.352
- adds Insurance Code § 1367.353
- adds Insurance Code § 1367.354
- adds Insurance Code § 1367.355
- adds Insurance Code § 1367.356
- adds Insurance Code § 1367.357
Bill text (Introduced)
By: Menéndez S.B. No. 336
A BILL TO BE ENTITLED
AN ACT
relating to health benefit plan coverage of treatments for pediatric neuroinflammatory disorder.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.
Chapter 1367, Insurance Code, is amended by adding Subchapter H to read as follows: SUBCHAPTER H. PEDIATRIC NEUROINFLAMMATORY DISORDERS
Sec. 1367.351. DEFINITIONS. In this subchapter:
(1) "Off-label use" means the use of a prescription drug or therapy approved for use by the United States Food and Drug Administration in a manner other than the approved use.
(2) "Pediatric neuroinflammatory disorder" means an immune-mediated inflammatory condition affecting the central nervous system in an individual younger than 18 years of age, including but not limited to autoimmune encephalitis, post-infectious encephalitis, acute disseminated encephalomyelitis (ADEM), optic neuritis, transverse myelitis, neuromyelitis optica spectrum disorder (NMOSD), pediatric acute-onset neuropsychiatric syndrome (PANS), pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), and other clinically recognized neuroimmune or neuroinflammatory disorders diagnosed by a physician using accepted clinical criteria, diagnostic testing, and clinical judgment.
Sec. 1367.352. APPLICABILITY OF SUBCHAPTER. (a) This subchapter applies only to a health benefit plan that provides benefits for medical, surgical, or prescription drug expenses incurred as a result of a health condition, accident, or sickness, including an individual, group, blanket, or franchise insurance policy or insurance agreement, a group hospital service contract, or an individual or group evidence of coverage or similar coverage document that is issued by:
(1) an insurance company;
(2) a group hospital service corporation operating under Chapter 842;
(3) a health maintenance organization operating under Chapter 843;
(4) an approved nonprofit health corporation that holds a certificate of authority under Chapter 844;
(5) a multiple employer welfare arrangement that holds a certificate of authority under Chapter 846;
(6) a stipulated premium company operating under Chapter 884;
(7) a fraternal benefit society operating under Chapter 885;
(8) a Lloyd's plan operating under Chapter 941; or
(9) an exchange operating under Chapter 942.
(b) Notwithstanding any other law, this subchapter applies to:
(1) a basic coverage plan under Chapter 1551;
(2) a basic plan under Chapter 1575; and
(3) a primary care coverage plan under Chapter 1579.
Sec. 1367.353. COVERAGE REQUIRED. (a) A health benefit plan must provide coverage for the treatment of pediatric neuroinflammatory disorder if:
(1) that condition was diagnosed by a physician with appropriate specialty training, including neurology, pediatric neurology, pediatric immunology, pediatric rheumatology, and an equivalent specialty, based on accepted clinical criteria, diagnostic testing, and the physician's clinical judgment;
(2) the treatment is prescribed by the enrollee's treating physician as medically necessary for an individual diagnosed with that condition; and
The text continues: full text of SB 336.
Links
- Full bill text (Introduced), Markdown copy of the official file
- Record, history and review for AI agents
- Official bill history on Texas Legislature Online
Texas Bill Atlas is an independent research tool, not an official state website.